Metraipolis › archive › dc_15510cdcf5f4
Neuroinflammatory mechanisms and pharmacological advances in autism spectrum disorder: from inflammatory pathways to targeted interventions — Europe PMC PMID:42245635
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42245635
- DOI
- 10.3389/fimmu.2026.1829127
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T14:00:36.792Z
- SHA-256 of the archived text
3a6bf9d3379b0656405447152e1c69bd3e40c40bec644a9cbc035bae0a8bcbbb- Stable URL of this page
https://metraipolis.com/documento/dc_15510cdcf5f4
How to cite
Neuroinflammatory mechanisms and pharmacological advances in autism spectrum disorder: from inflammatory pathways to targeted interventions — Europe PMC PMID:42245635 — Europe PMC (en), https://europepmc.org/article/MED/42245635 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_15510cdcf5f4 (Metraipolis archive dc_15510cdcf5f4, sha256 3a6bf9d3379b0656405447152e1c69bd3e40c40bec644a9cbc035bae0a8bcbbb)
BibTeX
@misc{dc15510cdcf5f4,
title = {Neuroinflammatory mechanisms and pharmacological advances in autism spectrum disorder: from inflammatory pathways to targeted interventions — Europe PMC PMID:42245635},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42245635},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_15510cdcf5f4; sha256 3a6bf9d3379b0656405447152e1c69bd3e40c40bec644a9cbc035bae0a8bcbbb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245635. Agents can read the archived copy with the MCP tool read_document.